The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide

Jan 10, 2012Neuropharmacology

How nausea relates to reduced eating and weight loss from injected GLP-1 drugs exendin-4 and liraglutide

AI simplified

Abstract

All doses of exendin-4 that suppress food intake also produce conditioned taste avoidance.

  • One dose of liraglutide suppresses food intake without causing conditioned taste avoidance.
  • Chronic administration of exendin-4 leads to increased ingestion of nonnutritive substances while maintaining reduced food intake and body weight.
  • The pica response from exendin-4 is linked to brain activation rather than vagal pathways.
  • Exendin-4 administration to the medial subnucleus of the nucleus tractus solitarius reduces food intake and triggers a pica response, indicating this area may mediate nausea responses.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free